Nitric Oxide Enhances Expression and Shedding of Tumor Necrosis Factor Receptor I (p55) in Endothelial Cells
Authors:
- 1 June 2000
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 20 (6) , 1506-1511
Abstract
—The biological actions of tumor necrosis factor-α (TNF-α) are mediated by 2 distinct receptors, TNF-RI (p55) and TNF-RII (p75). The extracellular domains of both receptors are shed in soluble form (sTNF-RI and sTNF-RII). The soluble receptors are involved in regulating TNF-α activities and may have therapeutic potential as TNF-neutralizing agents. However, it remains unclear as to what kind of physiological molecule can regulate TNF receptors. Nitric oxide (NO) mediates a variety of biological and pathophysiological functions. We hypothesized that NO may modulate the expression and shedding of TNF-RI. An NO donor, diethylamine/NO complex (NOC 5), increased sTNF-RI in the supernatants of ECV304, a human umbilical vein cell line, in a dose-dependent manner. TNF-RI mRNA in these cells was upregulated by NOC 5. 8-Br-cGMP and peroxynitrate had no effect on sTNF-RI release. Genistein and herbimycin A, inhibitors of tyrosine kinase, inhibited sTNF-RI release. Herbimycin A inhibited the levels of TNF-RI mRNA enhanced by NOC 5, which downregulated the surface expression of TNF-RI, indicating that NO is also involved in the shedding process of TNF-RI. The shedding of TNF-RI was abolished by a synthetic inhibitor of matrix metalloproteinase, KB-R8301. In conclusion, NO enhanced the release of sTNF-RI from endothelial cells by a cGMP-independent mechanism. Dual pathways suggested for NO-induced sTNF-RI release include (1) enhanced expression of TNF-RI, at least partially, by a tyrosine kinase–dependent mechanism and (2) increased shedding of TNF-RI by a type of metalloproteinase.Keywords
This publication has 49 references indexed in Scilit:
- An Essential Role for Ectodomain Shedding in Mammalian DevelopmentScience, 1998
- A Cellular Striptease ActScience, 1998
- The Role of Tumor Necrosis Factor-α Receptors in AtherosclerosisTrends in Cardiovascular Medicine, 1998
- Reactive Oxygen Species as Mediators of Signal Transduction in Cardiovascular DiseaseTrends in Cardiovascular Medicine, 1998
- Nitric oxide stimulates stress‐activated protein kinases in glomerular endothelial and mesangial cellsFEBS Letters, 1996
- Two tumour necrosis factor receptors: structure and functionTrends in Cell Biology, 1995
- Nitric oxide mediates network oscillations of olfactory interneurons in a terrestrial molluscNature, 1994
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992
- Detection and localization of tumor necrosis factor in human atheromaThe American Journal of Cardiology, 1990
- Downregulation of tumor necrosis factor (TNF) sensitivity via modulation of TNF binding capacity by protein kinase C activators.Journal of Experimental Medicine, 1987